ANVS - Annovis Bio, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.64 0.21 (12.8%)	---	---	---	-0.02 (-1.18%)	0.2 (12.35%)	0.0 (0.0%)	0.0 (0.0%)

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.32
Diluted EPS:: -0.32
Basic P/E:: -5.7813
Diluted P/E:: -5.7813
RSI(14) 1m:: 100.0
VWAP:: 1.85
RVol:: 0.8151

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.81 +0.02 (+1.12%)	Oct 15 15:56
1m	Price increase 1m	1.83 +0.03 (+1.67%)	Oct 15 15:16
1m	Price increase 1m	1.81 +0.02 (+1.12%)	Oct 15 15:15
1m	Price decrease 1m	1.83 -0.02 (-1.04%)	Oct 15 14:52
1m	Price increase 1m	1.83 +0.02 (+1.04%)	Oct 15 14:43